JM

Jerome Marzinski

Chief Executive Officer

OxSonics Therapeutics

Paris, Ile-de-France


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
OxSonics Therapeutics
Industry
medical devices
Employees
16.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
24636739.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Nginx Gravity Forms Mobile Friendly WordPress.org Google Tag Manager SharePoint Basis

Keywords

drug delivery oncology medical devices immune oncology medical equipment manufacturing ultrasound therapy anti-cancer drugs sonotran platform tumor penetration solid tumors drug reformulation treatment efficacy clinical outcomes intra-tumoral administration targeted therapy biologics enhancement pharmaceutical partnerships novel therapies drug transport clinical trials radiologists collaboration oncology research patient care pathways infusion therapy cavitation microscale particles systemic delivery therapeutic devices tumor response preclinical studies pharma collaborations anti-cancer agents biomedical engineering enhanced drug efficacy tumor targeting intravenous therapy drug absorption drug toxicity reduction patient safety oncology solutions therapeutic index tumor mass intuitive device clinical integration drug compatibility real-time monitoring outpatient care cancer treatment virotherapy lung cancer mcrc treatment hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans